Showing results (241-250 of 427) with videos related to
Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumabShanu Modi, Alison Stopeck, Hannah Linden, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary glandKotha Subbaramaiah, Louise R Howe, Priya Bhardwaj, et al.JAMA|April 13, 2006
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancerDonald A Berry, Constance Cirrincione, I Craig Henderson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancerG D'Andrea, D Fennelly, L Norton, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2011
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancerM N Fornier, P G Morris, A Abbruzzi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacyC Hudis, A Seidman, J Baselga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343Kevin S Hughes, Lauren A Schnaper, Jennifer R Bellon, et al.Journal of the American Geriatrics Society|July 27, 2006
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapyArti Hurria, Anju Hurria, Enid Zuckerman, et al.Clinical Breast Cancer|January 5, 2016
Biomarkers That Predict Sensitivity to Heat Shock Protein 90 InhibitorsKomal Jhaveri, Sarat Chandarlapaty, Neil Iyengar, et al.Clinical Breast Cancer|May 19, 2005
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxaneShanu Modi, Violante E Currie, Andrew D Seidman, et al.Pageof 43